ArticleCurrent drug delivery2025

Investigation of Dual-Loaded Doxorubicin and Sorafenib Liposomes Co-Modified with Glycyrrhetinic Acid and Cell-Penetrating Peptide TAT.

Houlin Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.